Abstract:Migraine affects over 40 million Americans and is the world's second most disabling condition. As the majority of medical care for migraine occurs in primary care settings, not in neurology nor headache subspecialty practices, healthcare system interventions should focus on primary care. Though there is grade A evidence for behavioral treatment (e.g., biofeedback, cognitive behavioral therapy (CBT), and relaxation techniques) for migraine, these treatments are underutilized. Behavioral treatments may be a valuable alternative to opioids, which remain widely used for migraine, despite the US opioid epidemic and guidelines that recommend against them. Identifying and removing barriers to the use of headache behavioral therapy could help reduce the disability as well as the personal and social costs of migraine. These techniques will have their greatest impact if offered in primary care settings to the lower socioeconomic status groups at greatest risk for migraine. We review the societal and cultural challenges that impose barriers to optimal use of non-pharmacological treatment services. These barriers include insufficient knowledge of migraine/headache behavioral treatments and insufficient availability of clinicians trained in non-pharmacological treatment delivery; limited access in underserved communities; financial burden; and stigma associated with both headache and mental health diagnoses and treatment. For each barrier, we discuss potential approaches to minimizing its effect and thus enhancing non-pharmacological treatment utilization.Case ExampleA 25-year-old graduate student with a prior history of headaches in college is attending school in the evenings while working a full-time job. Now, his headaches have significant nausea and photophobia. They are twice weekly and are disabling enough that he is unable to complete homework assignments. He does not understand why the headaches occur on Saturdays when he pushes through all week to get through his examinations that take place on Friday evenings. He tried two different migraine preventive medications, but neither led to the 50% reduction in headache days his doctor had hoped for. His doctor had suggested cognitive behavioral therapy (CBT) before initiating the medications, but he had been too busy to attend the appointments, and the challenges in finding an in-network provider proved difficult. Now with the worsening headaches, he opted for the CBT and by the fifth week had already noted improvements in his headache frequency and intensity.

Headache Treatment Options

Nonpharmacologic Treatment Options in Pediatric Tension-Type Headache Patients: A Systematic Review

Non-Pharmacological Treatment of Primary Headaches—A Focused Review

Why headache treatment fails

Frequent Headaches: Evaluation and Management

Acute treatment of migraine headaches

Approach to the Patient With Headache

[Non-medical Approaches to Headache Prevention: What is the Evidence?]

Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors

Identifying and Treating Underlying Medical Illness

Headache Disorders: Differentiating Primary and Secondary Etiologies

Complementary and integrative medicine in the management of headache

Breakthroughs on the Clinical Management of Headache and Questions That Need to Be Solved.

Management of Medication Overuse Headaches

Non-CGRP Antagonist/Non-Triptan Options for Migraine Disease Treatment: Clinical Considerations

A Review on Osteopathic Manipulation in Patients With Headache

Beyond pain control: Outcome and treatment preferences in pediatric migraine

Advancements in pediatric headache

International Headache Society global practice recommendations for the acute pharmacological treatment of migraine

Migraine Treatment: When, Why, and How to Introduce Antimigraine Therapies

Non‐pharmacological management of persistent headaches associated with neck pain: A clinical practice guideline from the Ontario protocol for traffic injury management (OPTIMa) collaboration